EOC Pharma Group Funding: $32M Raised, Series B (2017)
EOC Pharma Group is based in Oudenaarde, Belgium. It has raised $32M in total funding. Latest round: Series B.
EOC Pharma Group funding overview
EOC Pharma Group is based in Oudenaarde, Belgium. EOC Pharma Group has raised $32M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2017. The round record for EOC Pharma Group runs through 2017; nothing later has been disclosed. Investors on record include Taikang Industry Development Fund, Sequoia China, H&Q Asia Pacific. 3 distinct backers are named across the disclosed rounds.
EOC Pharma Group at a glance
Total raised
$32M
Latest round
Series B
Latest round date
November 2017
Headquarters
Oudenaarde, Belgium
Notable investors
Taikang Industry Development Fund, Sequoia China, H&Q Asia Pacific
Frequently asked about EOC Pharma Group funding
How much has EOC Pharma Group raised?
EOC Pharma Group has raised $32M in total disclosed funding across the rounds on record.
Who has invested in EOC Pharma Group?
Taikang Industry Development Fund, Sequoia China, H&Q Asia Pacific are named among the investors backing EOC Pharma Group.
What was the latest EOC Pharma Group funding round?
The most recent disclosed round is a Series B, announced in November 2017.
Where is EOC Pharma Group based?
EOC Pharma Group is based in Oudenaarde, Belgium.
When did EOC Pharma Group last raise?
The last disclosed EOC Pharma Group round closed in November 2017 at Series B.
EOC Pharma Group totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Oudenaarde below to benchmark round size and investor mix.
